Spacers in radiotherapy treatment of prostate cancer: Is reduction of toxicity cost-effective?

201563 citationsJournal Articlehybrid Open Access

Authors

IMRT+S is cost-effective compared to IMRT-O based on its potential to reduce radiotherapy-related toxicity.

Published in: Radiotherapy and Oncology

Volume 114, Issue 2, pp. 276-281

Field-Weighted Citation Impact: 6.90